EPTM.F Stock Overview
A biomedical company, develops and commercializes ingestible therapeutic devices worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Epitomee Medical Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.99 |
| 52 Week High | ₪1.05 |
| 52 Week Low | ₪0.95 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | -3.20% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 3.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| EPTM.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 2.2% |
| 1Y | n/a | 21.9% | 32.6% |
Return vs Industry: Insufficient data to determine how EPTM.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how EPTM.F performed against the US Market.
Price Volatility
| EPTM.F volatility | |
|---|---|
| EPTM.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: EPTM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EPTM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Dan Hashimshony | www.epitomeemedical.com |
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule.
Epitomee Medical Ltd Fundamentals Summary
| EPTM.F fundamental statistics | |
|---|---|
| Market cap | US$26.89m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs EPTM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPTM.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EPTM.F perform over the long term?
See historical performance and comparison